CLSI POCT09
Selection Criteria for Point-of-Care Testing Devices
CLSI POCT09A helps healthcare professionals select of point-of-care testing devices that meet the need of both the patient and clinicians. This guidance simplifies the selection process, ensuring that immediate test results can be accurately obtained, allowing healthcare professionals to make informed decisions on patient care.
This reaffirmed document has been reviewed and confirmed as suitable to remain published without revision of content, as of January 2017.
{{FormatPrice(currentPrice)}}
Free
{{FormatPrice(nonMemberPrice)}} List PriceClinical and Laboratory Standards Institute document POCT09-A—Selection Criteria for Point-of-Care Testing Devices; Approved Guideline provides guidance on selection of point-of-care testing (POCT) devices based on the patient care setting and clinical needs. This guidance document is intended to reflect the selection process of instrumented diagnostic systems that can be used at or near the site of patient care. Overall, this guidance document is designed to assist and benefit personnel responsible for the evaluation, negotiation, and selection process including laboratory, management, and information technology. It includes discussions on important factors when considering POCT through clinical and operational needs assessment. In addition, regulatory and accreditation requirements on various POCT or devices are explained, along with the various appendices that serve as a tool for POCT device implementation.
This document is designed as an aid for laboratory and facility management to simplify and facilitate the point-of-care testing (POCT) device selection process and allow evaluation of these devices to identify those that are optimal for the patient care setting and population served. The device evaluation process will lead to an increased awareness of the device’s testing process and risk associated with use of the device. In addition, long-term benefits can be achieved with improved operational and compliance processes. Thus, patient care, quality, and compliance will be maximized.
This guidance document is intended to reflect the selection process of instrumented diagnostic systems that can be used at or near the site of patient care. Purposely excluded from this discussion are large central laboratory analyzers, noninstrumented testing (eg, dip sticks, visual read lateral flow devices), and handheld glucose meters, which are the subject of other CLSI guidance documents, either already existing (eg, CLSI document C30(1)) or in development. Although these classes of diagnostics devices are excluded from specific discussion, many of the processes and concepts discussed herein have widespread utility across device classes.
This document is available in electronic format only.
Free
Clinical and Laboratory Standards Institute document POCT09-A—Selection Criteria for Point-of-Care Testing Devices; Approved Guideline provides guidance on selection of point-of-care testing (POCT) devices based on the patient care setting and clinical needs. This guidance document is intended to reflect the selection process of instrumented diagnostic systems that can be used at or near the site of patient care. Overall, this guidance document is designed to assist and benefit personnel responsible for the evaluation, negotiation, and selection process including laboratory, management, and information technology. It includes discussions on important factors when considering POCT through clinical and operational needs assessment. In addition, regulatory and accreditation requirements on various POCT or devices are explained, along with the various appendices that serve as a tool for POCT device implementation.
This document is designed as an aid for laboratory and facility management to simplify and facilitate the point-of-care testing (POCT) device selection process and allow evaluation of these devices to identify those that are optimal for the patient care setting and population served. The device evaluation process will lead to an increased awareness of the device’s testing process and risk associated with use of the device. In addition, long-term benefits can be achieved with improved operational and compliance processes. Thus, patient care, quality, and compliance will be maximized.
This guidance document is intended to reflect the selection process of instrumented diagnostic systems that can be used at or near the site of patient care. Purposely excluded from this discussion are large central laboratory analyzers, noninstrumented testing (eg, dip sticks, visual read lateral flow devices), and handheld glucose meters, which are the subject of other CLSI guidance documents, either already existing (eg, CLSI document C30(1)) or in development. Although these classes of diagnostics devices are excluded from specific discussion, many of the processes and concepts discussed herein have widespread utility across device classes.
This document is available in electronic format only.